These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35048789)

  • 1. Serum CCL28 as a biomarker for diagnosis and evaluation of Sjögren's syndrome.
    Yu X; Zhu F; Yu X; Wang J; Wu B; Li C
    Scand J Rheumatol; 2023 Mar; 52(2):200-207. PubMed ID: 35048789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum 14-3-3η protein is associated with clinical and serologic features of Sjögren's syndrome in patients with systemic lupus erythematosus: a cross-sectional analysis.
    Hammam N; Gamal NM; Elzohri MH; Elsonbaty AM; Rashed AM; Eldaly ZH; Tarik D; Gheita TA
    Clin Rheumatol; 2020 Sep; 39(9):2603-2610. PubMed ID: 32206972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
    Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
    J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of salivary CCL28 in primary Sjögren's syndrome.
    Hernandez-Molina G; Burkhardt AM; Lima G; Zlotnik A; Betanzos JL; Bahena S; Llorente L
    Rheumatol Int; 2015 Aug; 35(8):1431-4. PubMed ID: 25567740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
    Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
    Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands.
    Kang KY; Kim HO; Kwok SK; Ju JH; Park KS; Sun DI; Jhun JY; Oh HJ; Park SH; Kim HY
    Arthritis Res Ther; 2011; 13(5):R179. PubMed ID: 22030011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of systemic lupus erythematosus (SLE) to rheumatoid arthritis (RA), discoid lupus erythematosus (DLE) and Sjögren's syndrome. A clinical study.
    Bencze G
    Acta Rheumatol Scand; 1970; 16(3):191-6. PubMed ID: 5488864
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
    Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
    J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of alpha-fodrin antibodies in the diagnosis of Sjögren's syndrome.
    Turkçapar N; Olmez U; Tutkak H; Duman M
    Rheumatol Int; 2006 Feb; 26(4):354-9. PubMed ID: 15990993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sjögren's syndrome in systemic lupus erythematosus and rheumatoid arthritis: immune effector cells in salivary glands.
    Malmström M; Seppä A; Konttinen YT; Helve T; Reitamo S
    Rheumatol Int; 1983; 3(1):1-5. PubMed ID: 6604304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Previous diagnosis of Sjögren's Syndrome as rheumatoid arthritis or systemic lupus erythematosus.
    Rasmussen A; Radfar L; Lewis D; Grundahl K; Stone DU; Kaufman CE; Rhodus NL; Segal B; Wallace DJ; Weisman MH; Venuturupalli S; Kurien BT; Lessard CJ; Sivils KL; Scofield RH
    Rheumatology (Oxford); 2016 Jul; 55(7):1195-201. PubMed ID: 26998859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
    Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
    J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics and labial gland pathological features in children with systemic lupus erythematosus complicated by Sjögren's syndrome].
    Cheng S; Xue HY; Cao LF
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Jul; 26(7):695-700. PubMed ID: 39014945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
    Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
    Front Immunol; 2021; 12():673658. PubMed ID: 34012457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.